上海医药 (02607.HK)

+ 收藏

财务摘要(报告期)(上海医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
原始币种(元) 人民币人民币人民币人民币人民币人民币人民币人民币
每股指标:
 每股收益EPS基本(元) 1.021.030.710.411.611.451.130.44
 每股净资产(元) 18.5018.5018.1918.5418.1417.9017.6722.70
 每股经营现金净流量(元) 1.410.620.44-0.711.28-0.04-0.15-0.88
 每股现金流量净额(元) 0.800.551.12-0.121.190.791.175.09
 每股营业收入(元) 70.2953.3335.8017.9162.7447.2430.2220.02
盈利能力:
 销售毛利率(%) 12.0412.1312.8713.0413.1412.9913.4512.88
 销售净利率(%) 1.982.512.582.953.013.434.092.69
 净资产收益率平均(%) 5.565.603.882.249.658.336.442.20
 总资产净利率(%) 1.841.851.270.753.112.692.110.72
 投入资本回报率ROIC(%) 2.292.291.580.933.863.322.630.94
收益质量:
 营业利润/利润总额(%) 131.52126.12125.37124.52123.04120.31117.77127.26
 税项/利润总额(%) 26.7624.0124.6321.6220.6220.9320.7322.87
 经营活动产生的现金流量净额/营业收入(%) 2.011.171.24-3.962.04-0.09-0.50-4.38
资本结构:
 资产负债率(%) 62.1162.4062.9961.2360.6360.6359.5459.14
 权益乘数 2.642.662.702.582.542.542.472.45
 产权比率 1.921.941.991.841.791.781.711.67
 流动资产/总资产(%) 76.6377.2477.2576.2875.4675.7874.8174.09
 非流动资产/总资产(%) 23.3722.7622.7523.7224.5424.2225.1925.91
 流动负债/负债合计(%) 92.9592.0592.5390.6092.1491.0189.6988.45
 非流动负债/负债合计(%) 7.057.957.479.407.868.9910.3111.55
 归属母公司股东的权益/投入资本(%) 40.3939.7739.5340.8941.9741.7043.5347.61
偿债能力:
 流动比率 1.331.341.331.381.351.371.401.42
 速动比率 1.031.061.061.091.041.111.121.15
 货币资金/流动负债(%) 24.9423.9025.2023.6624.7523.7426.7138.47
 营业利润/流动负债(%) 7.586.724.572.719.798.486.792.66
 经营活动产生的现金流量净额/流动负债(%) 4.281.881.32-2.304.29-0.15-0.56-2.62
 归属母公司股东的权益/负债合计(%) 52.0551.5150.1354.3555.8256.0858.6359.94
 经营活动产生的现金流量净额/负债合计(%) 3.971.731.22-2.083.95-0.13-0.50-2.31
 营业利润/负债合计(%) 7.056.184.232.469.027.726.092.35
成长能力:
 总资产同比增长率(%) 6.989.5213.9813.1921.2319.1818.1316.66
 每股净资产同比增长率(%) 2.023.342.92-18.334.434.575.2736.02
 总负债同比增长率(%) 9.5812.7120.5917.2015.1012.1910.188.41
 基本每股收益同比增长率(%) -36.65-28.97-37.17-6.82-10.06-8.23-10.32-41.33
 归属母公司股东的权益同比增长率(%) 2.183.533.116.2735.8736.0036.9136.04
 营业利润同比增长率(%) -14.39-9.70-16.1822.737.7810.9210.79-27.27
 营业收入同比增长率(%) 12.2113.1118.7016.397.498.476.1510.27
 股东权益合计同比增长率(%) 2.984.604.267.4032.0631.8432.1731.09
营运能力:
 存货周转率次(次) 6.444.993.421.736.555.483.521.89
 流动资产周转率次(次) 1.671.260.840.431.741.320.870.45
 固定资产周转率次(次) 21.9717.4311.615.7821.0717.1310.895.49
 总资产周转率次(次) 1.270.960.640.331.280.980.640.33
衍生指标:
 现金及现金等价物净增加额TTM(元) 2,965,917,695.383,499,564,356.314,207,831,890.34-10,506,469,202.994,396,391,086.062,679,494,206.504,131,115,595.8315,229,442,422.75
 利润总额TTM(元) 7,054,296,738.487,759,446,265.867,584,182,835.049,313,672,602.528,808,353,281.138,915,138,641.448,684,214,655.327,133,279,657.86
 毛利TTM(元) 31,328,141,942.2931,771,281,908.2232,516,056,372.9631,791,036,275.6430,486,376,677.0429,508,705,488.2629,559,803,549.6628,919,532,539.01
 投入资本(元) 169,652,877,410.18172,248,821,537.56170,396,509,203.02167,681,899,999.25159,794,060,362.32158,685,764,629.98150,062,491,047.24135,535,049,759.33
 经营活动产生的现金流量净额TTM(元) 5,231,519,727.107,204,575,571.426,937,966,190.284,610,166,293.824,743,361,181.871,977,941,628.882,334,127,196.063,671,243,437.31
 总营业收入TTM(元) 260,295,088,943.53254,877,695,080.07252,865,992,760.24241,309,544,141.33231,981,299,764.51229,463,466,511.53222,294,254,480.98221,122,488,544.79
 归属母公司净利润TTM(元) 3,767,999,581.184,600,016,489.094,531,367,309.585,883,782,671.535,617,152,003.015,423,141,496.895,221,313,819.984,224,340,845.54
 所得税TTM(元) 1,887,726,454.221,797,913,625.521,739,386,476.761,900,943,681.921,816,338,512.582,020,268,249.912,010,216,392.811,704,364,729.37
截止日期(元) 2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院